Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2019
Price : $35 *
At a glance
- Drugs Tocilizumab (Primary) ; Prednisolone
- Indications Drug hypersensitivity
- Focus Therapeutic Use
- Acronyms COLAR
- 11 Feb 2019 Planned End Date changed from 1 May 2020 to 1 Jun 2020.
- 11 Feb 2019 Planned primary completion date changed from 1 Oct 2019 to 1 Jan 2020.
- 11 Feb 2019 Status changed from not yet recruiting to recruiting.